Albany, NY, Feb. 02, 2016 -- Transparency Market Research has published a new report on the global continuous glucose monitoring market. According to the report, the global continuous glucose monitoring market was valued at US$370 mn in 2012 and is predicted to reach US$910 mn by 2019. The report, titled ‘Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, states that the global continuous glucose monitoring market is predicted to expand at a 13.60% CAGR during the period from 2013 to 2019.
The demand for continuous glucose monitoring systems (CGMS) has increased rapidly as these systems display real-time glucose levels from the patient’s body at regular intervals. CGMS use wireless technology to measure glucose levels. As per the International Diabetes Federation (IDF), globally, about 382 mn people were identified with diabetes in 2013 and the number is predicted to reach 592 mn by 2035. The increasing number of people being diagnosed with diabetes is expected to propel the global continuous glucose monitoring market throughout the forecast period.
Get Expert Opinion in Detail Report:
http://www.transparencymarketresearch.com/continuous-glucose-monitoring.html
The global continuous glucose monitoring market is segmented on the basis of geography and device/brand. By device/brand, the global continuous glucose monitoring market is classified into guardian real time CGM system, freestyle navigator, dexcom seven plus CGM system, dexcom G4 platinum, minimed paradigm revel/veo system, and others. Based on device/brand, the global continuous glucose monitoring market is analyzed by factors such as sales revenue, commercial launch, usage, geographical presence, and technical developments. In terms of market share, in 2012, the guardian real time CGM system dominated the global continuous glucose monitoring market, followed by dexcom seven plus CGM systems. Demand for the dexcom G4 platinum CGM system also is predicted to expand rapidly during the forecast period.
The global continuous glucose monitoring market is widespread, as leading companies offer innovative CGMS in different regions. Some of the leading companies in the global continuous glucose monitoring market are Medtronic, Inc., Abbott Diabetes Care, Inc., Nova Biomedical Corporation, GlySens, Inc., Insulet Corporation, Dexcom, Inc., Bayer AG, and Senseonics, Inc.
Avail a Sample Copy of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1169
By geography, the global continuous glucose monitoring market is classified into North America, Europe, Asia Pacific, and Rest of the World. In 2012, North America led the global continuous glucose monitoring market. The North America continuous glucose monitoring market is driven by factors such as the rising obese population, increasing technical advancements in medical equipment, and increasing aging population. The Asia Pacific continuous glucose monitoring market is predicted to grow rapidly during the forecast period. Changing lifestyles, economic development, and increasing patient awareness are the driving factors for the Asia Pacific regional market.
Factors such as calibration issues and unfavorable reimbursement policies are predicted to hamper the growth of the global continuous glucose monitoring market. Increase in demand for point of care testing (POCT) is expected to create growth opportunities for the global continuous glucose monitoring market in the coming few years.
Key Segments of Global Continuous Glucose Monitoring Market
Continuous Glucose Monitoring Market, by Device/Brand
- Guardian Real Time CGM System
- FreeStyle Navigator
- Dexcom Seven Plus CGM System
- Dexcom G4 Platinum
- MiniMed Paradigm Revel/Veo System
- Others
Continuous Glucose Monitoring Market, by Geography
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Trending Report by Transparency Market Research:
- Blood Gas and Electrolyte Analyzer Market: http://www.transparencymarketresearch.com/blood-gas-electrolyte-analyzers.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr. Sudip.S 90 State Street, Suite 700 Albany, NY 12207 United States. Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



